Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs — Zhao Wang (2018) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs
Shared by
De Clercq Erik
KU Leuven
Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs
Article
2018
en
Authors
+7 more
ZW
Zhao Wang
YZ
Yu Zhao
DK
Dongwei Kang
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs
Ping Gao
,
Shu Song
,
Zhao Wang
,
Lin Sun
,
Jian Zhang
,
Christophe Pannecouque
,
De Clercq Erik
,
Peng Zhan
,
Xinyong Liu
Article
2009
Design, Synthesis and Anti-HIV-1 Evaluation of Novel Arylazolylthioacetanilides as Potent NNRTIS
Xinyong Liu
,
Peng Zhan
,
Christophe Pannecouque
,
De Clercq Erik
Article
2017
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs
Zhaoqiang Liu
,
Ye Tian
,
Jinghan Liu
,
Boshi Huang
,
Dongwei Kang
,
De Clercq Erik
,
Dirk Daelemans
,
Christophe Pannecouque
,
Peng Zhan
,
Xinyong Liu
Article
2023
5-Cyano substituted diarylpyridines as potent HIV-1 NNRTIs: Rational design, synthesis, and activity evaluation
Hao Song
,
Yu Xia
,
Tao Zhang
,
Caiyun Dun
,
Bairu Meng
,
De Clercq Erik
,
Christophe Pannecouque
,
Dongwei Kang
,
Peng Zhan
,
Xinyong Liu
Article
2012
Structure-based bioisosterism design, synthesis and biological evaluation of novel 1,2,4-triazin-6-ylthioacetamides as potent HIV-1 NNRTIs
Peng Zhan
,
Xiao Li
,
Zhenyu Li
,
Xuwang Chen
,
Ye Tian
,
Wen‐Ming Chen
,
Xinyong Liu
,
Christophe Pannecouque
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.